The neutrophil percentage to albumin ratio (NPAR), a composite biomarker derived from neutrophil and albumin levels, has demonstrated efficacy in predicting inflammation in various conditions, such as acute kidney injury, septic shock, and rectal cancer (26). This evidence concerns the gene ALB and rectal cancer.